Profound Medical to Participate in the Stifel 2026 Healthcare Conference
What Profound Medical (PROF) Said on Its Q3 Earnings Call
Profound Medical (PROF) Q3 2026 Earnings Call Transcript
Profound Medical Corp (PROF) (Q3 2026) Earnings Call Highlights: Revenue Surges 86% as Pipeline ...
Profound Medical (PROF) Reports Q3 Loss, Beats Revenue Estimates
Profound Medical Corp. (PRN:CA) Q3 2026 Earnings Call Transcript
Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth
Profound Medical FY2026 Revenue expected to be more than $25.000M vs $26.800M Est
Profound Medical Q3 EPS $(0.21) Misses $(0.19) Estimate, Sales $9.830M Miss $9.867M Estimate
Profound Medical Says Cook Medical Has No Purchase Obligations Before FDA Clearance; Missing Minimum Sales Targets Not A Breach
Wall Street Analysts Believe Profound Medical (PROF) Could Rally 89.93%: Here's is How to Trade
Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth
Profound Medical Strikes Supply, Distribution Deal With iMRI Division Of Cook Medical To Expand Sales Of TULSA-PRO System In U.S.
Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect?
TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
Profound Medical and Telix Pharmaceuticals Partner to Advance Prostate Cancer Imaging and Treatment Education
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
Profound Medical: Q3 Revenue Beats Outlook (Rating Upgrade)
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.